A Double Blinded, Randomized, Controlled Investigation of Taurolidine-citrate/Heparin Catheter Lock Solution Versus Heparin in Patients on Home Parenteral Nutrition With Previously Proven High Risk of Catheter Related Blood Stream Infections

Trial Profile

A Double Blinded, Randomized, Controlled Investigation of Taurolidine-citrate/Heparin Catheter Lock Solution Versus Heparin in Patients on Home Parenteral Nutrition With Previously Proven High Risk of Catheter Related Blood Stream Infections

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Apr 2016

At a glance

  • Drugs Taurolidine (Primary) ; Heparin
  • Indications Bacterial infections; Embolism and thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Apr 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Aug 2016 as reported by ClinicalTrials.gov.
    • 19 Jun 2014 Planned End Date changed from 1 Nov 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov.
    • 19 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top